Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
Background. Multiple studies and meta-analyses examined the role of traditional risk factors for cardiovascular events in statin treatment-naive patients. Nowadays, millions receive such therapy for the primary prevention of cardiovascular events (CVE). Objective. CVEs still occur in patients on pri...
Saved in:
Main Authors: | Dennis Steenhuis, Stijn de Vos, Jens Bos, Eelko Hak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2022/6587165 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PharmRL: pharmacophore elucidation with deep geometric reinforcement learning
by: Rishal Aggarwal, et al.
Published: (2024-12-01) -
scPharm: Identifying Pharmacological Subpopulations of Single Cells for Precision Medicine in Cancers
by: Peng Tian, et al.
Published: (2025-01-01) -
InceptionDTA: Predicting drug-target binding affinity with biological context features and inception networks
by: Mahmood Kalemati, et al.
Published: (2025-02-01) -
Insights into simulation-based learning: student and faculty experiences in a PharmD program in Saudi Arabia
by: Reem Binsuwaidan, et al.
Published: (2025-02-01) -
Cover, Content, and Editorial Note from Borneo J Pharm Vol. 7 No. 4 November 2024
by: Chief Editor of Borneo J Pharm
Published: (2024-11-01)